Moreover, overexpression of MYC confers survival benefit to cancer cells by increasing the synthesis of biomolecules and energy production during hypoxic stress [44], thus signifying that it could be a potential drug target for anti-cancer therapies. This evidence concerns the gene MYC and cancer.